Financiado en parte por Verdure Sciences, verdure sciences
Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial
Smith SJ, Lopresti AL, Fairchild TJ
Journal of psychopharmacology (Oxford, England) · 33 citas
Etiquetas de revisión
Financiado por la industriaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiado por la industria
- Empresa
- Verdure Sciences
- Empresa
- verdure sciences
Según 2 financiadores declarados.
Publicación
- Publicado
- 2023-09-23 · J Psychopharmacol · vol. 37 · número 11 · págs. 1091–1104
- Editorial
- SAGE Publishing
- Citado
- 49 citas · más que el 99% de estudios similares · 15.4× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 81 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Phytochemicals and Medicinal Plants · Mindfulness and Compassion Interventions · Multidisciplinary Research Papers Compilation
- Palabras clave
- Placebo, Withania somnifera, Medicine, Randomized controlled trial, Perceived Stress Scale, Physical therapy, Placebo-controlled study, Testosterone (patch), Internal medicine, Double blind, Stress (linguistics)
- MeSH
- humans, withania, obesity, fatigue, plant extracts, double-blind method, adult, female, male, overweight
3 autores
- Stephen James Smith🇦🇺 · autor de correspondenciaMurdoch University
- Adrian L. Lopresti🇦🇺Murdoch University
- Timothy J. Fairchild🇦🇺Murdoch University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Stress is a state of homeostasis in the body being challenged, resulting in a systemic response. It has become more prevalent in recent years and affects mental and physical health.
Aims
Evaluate the effects of ashwagandha on stress, fatigue, and sex hormones in overweight or mildly obese men and women with self-reported stress and fatigue.
Methods
Two-arm, parallel-group, 12-week, randomized, double-blind, placebo-controlled trial on overweight or mildly obese men and women aged 40-75 years, supplementing with 200 mg of an ashwagandha root extract (Witholytin®) twice daily.
Results/outcomes
Supplementation with ashwagandha was associated with a significant reduction in stress levels based on the Perceived Stress Scale (primary outcome); however, the improvements were not significantly different to the placebo group (p = 0.867). Based on the Chalder Fatigue Scale, there was a statistically significant reduction in fatigue symptoms in the ashwagandha group compared to the placebo group (p = 0.016), and participants taking ashwagandha also experienced a significant increase in heart rate variability (p = 0.003). However, there were no significant between-group differences in other self-report outcome measures. In the men taking ashwagandha, there was a significant increase in the blood concentrations of free testosterone (p = 0.048) and luteinizing hormone (p = 0.002) compared to the placebo group.
Conclusions/interpretation
The results of this study suggest that in overweight middle-to-older age adults experiencing high stress and fatigue, compared to the placebo, ashwagandha did not have a significantly greater impact on perceived stress levels. However, based on secondary outcome measures, it may have anti-fatigue effects. This may be via its impact on the autonomic nervous system. However, further research is required to expand on these current findings.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.